DexCom Inc (DXCM)
114.98
-4.00 (-3.36%)
USD |
NASDAQ |
Mar 22, 16:00
114.77
-0.21 (-0.18%)
After-Hours: 20:00
DexCom Revenue (Quarterly): 815.20M for Dec. 31, 2022
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 815.20M |
| September 30, 2022 | 769.60M |
| June 30, 2022 | 696.20M |
| March 31, 2022 | 628.80M |
| December 31, 2021 | 698.20M |
| September 30, 2021 | 650.20M |
| June 30, 2021 | 595.10M |
| March 31, 2021 | 505.00M |
| December 31, 2020 | 568.90M |
| September 30, 2020 | 500.90M |
| June 30, 2020 | 451.80M |
| March 31, 2020 | 405.10M |
| December 31, 2019 | 462.80M |
| September 30, 2019 | 396.30M |
| June 30, 2019 | 336.40M |
| March 31, 2019 | 280.50M |
| December 31, 2018 | 338.00M |
| September 30, 2018 | 266.70M |
| June 30, 2018 | 242.50M |
| March 31, 2018 | 184.40M |
| December 31, 2017 | 221.00M |
| September 30, 2017 | 184.60M |
| June 30, 2017 | 170.60M |
| March 31, 2017 | 142.30M |
| December 31, 2016 | 171.20M |
| Date | Value |
|---|---|
| September 30, 2016 | 148.60M |
| June 30, 2016 | 137.30M |
| March 31, 2016 | 116.20M |
| December 31, 2015 | 130.80M |
| September 30, 2015 | 105.20M |
| June 30, 2015 | 93.20M |
| March 31, 2015 | 72.80M |
| December 31, 2014 | 84.30M |
| September 30, 2014 | 69.00M |
| June 30, 2014 | 58.80M |
| March 31, 2014 | 47.10M |
| December 31, 2013 | 51.70M |
| September 30, 2013 | 42.90M |
| June 30, 2013 | 35.80M |
| March 31, 2013 | 29.60M |
| December 31, 2012 | 33.30M |
| September 30, 2012 | 23.10M |
| June 30, 2012 | 23.40M |
| March 31, 2012 | 20.10M |
| December 31, 2011 | 22.46M |
| September 30, 2011 | 18.25M |
| June 30, 2011 | 21.42M |
| March 31, 2011 | 14.17M |
| December 31, 2010 | 15.60M |
| September 30, 2010 | 11.66M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
184.40M
Minimum
Mar 2018
815.20M
Maximum
Dec 2022
489.63M
Average
481.85M
Median
Revenue (Quarterly) Benchmarks
| Abbott Laboratories | 10.09B |
| Intuitive Surgical Inc | 1.655B |
| Vertex Pharmaceuticals Inc | 2.303B |
| Align Technology Inc | 901.52M |
| Boston Scientific Corp | 3.242B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 91.80M |
| Total Expenses (Quarterly) | 689.80M |
| EPS Diluted (Quarterly) | 0.22 |
| Enterprise Value | 43.94B |
| Gross Profit Margin (Quarterly) | 66.40% |
| Profit Margin (Quarterly) | 11.26% |
| Earnings Yield | 0.71% |
| Operating Earnings Yield | 0.80% |
| Normalized Earnings Yield | 0.7066 |